Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Choi, T. Kipps, R. Kurzrock (2016)
ATM Mutations in Cancer: Therapeutic ImplicationsMolecular Cancer Therapeutics, 15
J. Doorbar (2005)
The papillomavirus life cycle.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 32 Suppl 1
B. Vogelstein, K. Kinzler (2015)
The Path to Cancer --Three Strikes and You're Out.The New England journal of medicine, 373 20
Arturo Valle-Mendiola, Adriana Gutiérrez-Hoya, María Lagunas-Cruz, B. Weiss-Steider, I. Soto-Cruz (2016)
Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical CancerMediators of Inflammation, 2016
M. Rusan, Yvonne Li, P. Hammerman (2015)
Genomic Landscape of Human Papillomavirus–Associated CancersClinical Cancer Research, 21
A. Ojesina, Lee Lichtenstein, S. Freeman, C. Pedamallu, Ivan Imaz-Rosshandler, Trevor Pugh, A. Cherniack, L. Ambrogio, K. Cibulskis, B. Bertelsen, S. Romero-Cordoba, V. Treviño, K. Vazquez-Santillan, A. Guadarrama, A. Wright, Mara Rosenberg, F. Duke, Bethany Kaplan, Rui Wang, E. Nickerson, H. Walline, M. Lawrence, C. Stewart, S. Carter, A. McKenna, I. Rodríguez-Sánchez, Magali Espinosa-Castilla, K. Woie, L. Bjørge, E. Wik, M. Halle, E. Hoivik, C. Krakstad, Nayeli Gabiño, G. Gómez-Macías, L. Valdez-Chapa, M. Garza-Rodríguez, German Maytorena, J. Vázquez, Carlos Rodea, A. Cravioto, M. Cortés, H. Greulich, C. Crum, D. Neuberg, A. Hidalgo-Miranda, Claudia Escareño, L. Akslen, T. Carey, O. Vintermyr, S. Gabriel, H. Barrera-Saldana, J. Meléndez-Zajgla, G. Getz, H. Salvesen, M. Meyerson (2013)
Landscape of genomic alterations in cervical carcinomasNature, 506
G. Halec, L. Alemany, B. Lloveras, M. Schmitt, M. Alejo, F. Bosch, S. Tous, J. Klaustermeier, N. Guimerà, N. Grabe, B. Lahrmann, L. Gissmann, W. Quint, F. Bosch, S. Sanjosé, M. Pawlita (2014)
Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancerThe Journal of Pathology, 234
O. Reich, S. Regauer, K. Kashofer (2020)
Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study.Gynecologic oncology
O. Reich, S. Regauer, W. McCluggage, C. Bergeron, C. Redman (2017)
Defining the Cervical Transformation Zone and Squamocolumnar Junction: Can We Reach a Common Colposcopic and Histologic Definition?International Journal of Gynecological Pathology, 36
O. Reich, S. Regauer (2015)
Two major pathways of recurrent high‐grade squamous intraepithelial lesions of the cervixInternational Journal of Cancer, 137
J. Marel, R. Baars, I. Alonso, M. Pino, M. Sandt, J. Lindeman, B. Harmsel, M. Boon, F. Smedts, J. Ordi, A. Torné, D. Jenkins, W. Quint (2014)
Oncogenic Human Papillomavirus–infected Immature Metaplastic Cells and Cervical NeoplasiaThe American Journal of Surgical Pathology, 38
S. Balasubramanian, N. Brown, M. Reed (2002)
Role of genetic polymorphisms in tumour angiogenesisBritish Journal of Cancer, 87
S. Regauer, O. Reich, K. Kashofer (2019)
Thin variant of high‐grade squamous intraepithelial lesion – relationship with high‐risk and possibly carcinogenic human papilloma virus subtypes and somatic cancer gene mutationsHistopathology, 75
Margaretha Veltman, J. Flowers, J. Flowers, Tinde Andel, Tinde Andel, M. Schranz (2018)
Origins and geographic diversification of African rice (Oryza glaberrima)PLoS ONE, 14
Yu-Min Yeh, Shan-Ju Hsu, P. Lin, K. Hsu, Pei-Ying Wu, W. Su, Jang-Yang Chang, Meng-Ru Shen (2017)
The c.1085A>G Genetic Variant of CSF1R Gene Regulates Tumor Immunity by Altering the Proliferation, Polarization, and Function of MacrophagesClinical Cancer Research, 23
J. Martens, J. Arends, P. Linden, Bert Boer, T. Helmerhorst (2004)
Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell.Anticancer research, 24 2B
K. Shimabukuro, S. Ichinose, R. Koike, T. Kubota, M. Yamaguchi, M. Miyasaka, T. Aso (2001)
Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.Gynecologic oncology, 83 2
F. Smedts, F. Ramaekers, A. Hopman (2008)
CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high‐grade cervical intraepithelial neoplasiaHistopathology, 52
J. Doorbar, W. Quint, L. Banks, I. Bravo, M. Stoler, T. Broker, M. Stanley (2012)
The biology and life-cycle of human papillomaviruses.Vaccine, 30 Suppl 5
Huizhi Wang, Jonathan Brown, Shegan Gao, S. Liang, R. Jotwani, Huaxin Zhou, J. Suttles, D. Scott, R. Lamont (2013)
The Role of JAK-3 in Regulating TLR-Mediated Inflammatory Cytokine Production in Innate Immune CellsThe Journal of Immunology, 191
H. Hausen (2002)
Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2
O. Reich, S. Regauer (2016)
Thin HSIL of the Cervix: Detecting a Variant of High-grade Squamous Intraepithelial Lesions With a p16INK4a AntibodyInternational Journal of Gynecological Pathology, 36
Kai Wang, Mingyao Li, H. Hakonarson (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 38
J. Martens, F. Smedts, Diana Ploeger, T. Helmerhorst, F. Ramaekers, J. Arends, A. Hopman (2009)
Distribution Pattern and Marker Profile Show Two Subpopulations of Reserve Cells in the Endocervical CanalInternational Journal of Gynecological Pathology, 28
J. Doorbar (2016)
Model systems of human papillomavirus‐associated diseaseThe Journal of Pathology, 238
H. Hausen (2000)
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in CarcinogenesisJournal of the National Cancer Institute, 92
T. Darragh, T. Colgan, J. Cox, D. Heller, M. Henry, R. Luff, T. McCalmont, R. Nayar, J. Palefsky, M. Stoler, E. Wilkinson, R. Zaino, D. Wilbur (2012)
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations From the College of American Pathologists and the American Society for Colposcopy and Cervical PathologyJournal of Lower Genital Tract Disease, 16
M. Galgano, P. Castle, K. Atkins, W. Brix, Sarah Nassau, M. Stoler (2010)
Using Biomarkers as Objective Standards in the Diagnosis of Cervical BiopsiesThe American Journal of Surgical Pathology, 34
Erich Burghardt, Ostör Ag (1983)
Site and origin of squamous cervical cancer: a histomorphologic study.Obstetrics and gynecology, 62 1
(2006)
OnlineOpen: This
A. Goyal, L. Ellenson, E. Pirog (2019)
p16 Positive Histologically Bland Squamous Metaplasia of the CervixThe American Journal of Surgical Pathology, 44
(2020)
Squamous intraepithelial lesions of the uterine cervix
Debbie Strachan, B. Ruffell, Y. Oei, M. Bissell, L. Coussens, N. Pryer, D. Daniel (2013)
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cellsOncoimmunology, 2
Human papillomavirus (HPV)-induced invasive cervical squamous cell cancer (SCC) develop via high-grade squamous intraepithelial lesion (HSIL). In contrast to classic thick HSIL, thin HSIL (≤9 cell layers) are poorly documented. This study compares histology, HPV genotypes, and aberrations in 50 cancer genes of 45 thin HSIL to 45 thick HSIL, 20 pT1a SCC, and 40 ≥pT1b SCC. Thin HSIL arose from proliferating reserve cells within endocervical epithelium or immature metaplasia throughout the transformation zone after infection with high-risk HPV genotypes (36/45; 80%), and 20% non–high-risk HPV genotypes compared with 2.5% thick HSIL, pT1a SCC, and ≥pT1b SCC. Thin HSIL were multifocal proliferations with varying epithelial thickness between 1 and 2 to 9 cell layers, with occasional transitions to thick HSIL or concomitant lesions of thick HSIL. Overall, 40% thin HSIL were located distant to and most thick HSIL occurred near or at the squamocolumnar junction. Only 20% thick HSIL showed koilocytosis. All HSIL lacked somatic gene mutations, compared with 30% pT1a and 55%≥pT1b SCC. Overrepresented rare germline variants in the MET, JAK3, and FGFR3 genes occurred in all patient groups. In summary, thin and thick HSIL arose independently of somatic gene mutations. The maturation level of the squamous epithelium at the time of transforming infection determines if a thick HSIL develops directly from HPV-infected proliferating reserve cells via thin HSIL or in stratified glycogenated squamous epithelium via low-grade squamous intraepithelial lesion. These observations raise doubts about the biological relevance of separation into thin and thick HSIL. The oncogenic potential of HPV genotypes but also germline variants may influence the natural history.
The American Journal of Surgical Pathology – Wolters Kluwer Health
Published: Apr 6, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.